Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.
Bhatt DL, Kaski JC, Delaney S, Alasnag M, Andreotti F, Angiolillo DJ, Ferro A, Gorog DA, Lorenzatti AJ, Mamas M, McNeil J, Nicolau JC, Steg PG, Tamargo J, Tan D, Valgimigli M. Bhatt DL, et al. Among authors: kaski jc. Int J Cardiol. 2021 Aug 15;337:1-8. doi: 10.1016/j.ijcard.2021.05.012. Epub 2021 May 15. Int J Cardiol. 2021. PMID: 34000356 Free article.
Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.
Tziakas D, Chalikias G, Stakos D, Altun A, Sivri N, Yetkin E, Gur M, Stankovic G, Mehmedbegovic Z, Voudris V, Chatzikyriakou S, Garcia-Moll X, Serra A, Passadakis P, Thodis E, Vargemezis V, Kaski JC, Konstantinides S. Tziakas D, et al. Among authors: kaski jc. Am J Cardiol. 2014 May 1;113(9):1487-93. doi: 10.1016/j.amjcard.2014.02.004. Epub 2014 Feb 12. Am J Cardiol. 2014. PMID: 24630389
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A. Sulzgruber P, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp/pvz016. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 31119266 Review.
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing.
El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G. El Hadidi S, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):187-210. doi: 10.1093/ehjcvp/pvaa108. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 32941594
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.
Ciliberti G, Verdoia M, Merlo M, Zilio F, Vatrano M, Bianco F, Mancone M, Zaffalon D, Bonci A, Boscutti A, Infusino F, Coiro S, Stronati G, Tritto I, Gioscia R, Dello Russo A, Fedele F, Gallina S, Cassadonte F, Ambrosio G, Bonmassari R, De Luca G, Sinagra G, Capucci A, Kaski JC, Guerra F. Ciliberti G, et al. Among authors: kaski jc. Int J Cardiol. 2021 Mar 15;327:9-14. doi: 10.1016/j.ijcard.2020.11.040. Epub 2020 Nov 23. Int J Cardiol. 2021. PMID: 33242505
551 results